An Acatris-hosted seminar on the new generation of flax products made impact at Natural Products Expo West 2006 and marked the one-year anniversary of the Flax Lignan Information Bureau
Minneapolis – Acatris hosted a free seminar at the Natural Products Expo West Trade Show in Anaheim, California on the “New Generation of Flax Products” to help consumers, suppliers, distributors and media understand the science and growing demand for flax lignans and flax oil.
Acatris, the flax lignan leader, set the gold standard for the minimum amount needed, 50 mg a day of SDG, for therapeutic benefit, as well as research on the numerous health benefits of flax lignans, such as prostate health, breast health, reducing menopausal symptoms, providing support for men suffering from hair loss, and acne. Lignans are a group of phytochemicals found in many plants. Each type of lignan has a different structure and different health properties. The main and most studied flaxseed lignan is SDG.
Jocelyn Mathern, RD, technical advisor for Acatris and advisor for the Flax Lignan Information Bureau presented at the educational seminar explaining, “Flax lignans have been a driving force in the market for change. New science shows that flax lignans can benefit consumers in many ways. Yet, it is imperative to note that the research conducted and the health benefits discovered on flax lignans do not transfer to all forms of lignans. Flax lignan SDG is the most science-supported lignan.”
A high lignan diet is linked with many health benefits, including lowering the risk of certain cancers and cardiovascular disease. “Women with newly diagnosed breast cancer who ate 2 ½ tablespoons of flaxseed per day in a muffin reduced tumor cell growth; effects were similar to tamoxifen, a breast cancer drug; and there were no significant side effects reported,” reported Mathern.
However, most Americans still do not get enough lignans, less than 1 mg per day. The continued growth of flax oil and standardized flax lignan products is anticipated to encourage consumers to add varied forms of flax SDG into their daily diet routines to receive a standardized amount of lignans. “The number of products including standardized flax lignans has seen unprecedented growth,” said Mathern. “A dosage of 250 mg of Acatris’ LinumLife® EXTRA product provides the 50 mg of recommended SDG per day, and additional standardized lignan products are now penetrating the marketplace.”
Expo West 2006 also marked the one-year anniversary for the Flax Lignan Information Bureau (FLIB), www.flaxlignaninfo.com, which Acatris initiated in 2005 as a consumer education campaign, gaining marketplace leadership status that has driven sales and key business deals. “The FLIB continues to be a “go-to” source for consumers and retailers to learn more about flax lignan products, research and science behind lignans, as well as the various health benefits they can reap when attaining the recommended SDG amount per day,” said Mathern.
Acatris announced in November 2005, a 300-percent sales increase between March 1, 2005 and October 1, 2005 for their LinumLife® EXTRA product over the entire 2004 sales figures for the previous year. LinumLife® EXTRA is the first flax extract with a standardized 20% lignan concentration. Acatris secured a major licensing agreement with Archer Daniels Midland Company (ADM) regarding the sales of soy isoflavone extracts.
Acatris’ education campaign also played an essential part in a recent announcement between Acatris and ADM to form the first standardized flax lignan industry association, the Flax Lignan Association.
# # #
Acatris Inc.’s LinumLife® EXTRA is produced through a patented production process. A dosage of 250 mg of LinumLife® EXTRA provides 50 mg lignans. This ingredient offers the convenience for one-per-day lignan capsules or tablets. For more information on LinumLife® EXTRA or flax lignans, visit www.linumlife.com or visit the Flax Lignan Information Bureau at www.flaxlignaninfo.com.